Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MyFastRx vs Nurx

MyFastRx
Graded #170

Higher grade

vs+1.2000000000000028
Nurx
Graded #200

Lower grade

The verdict

MyFastRx takes it — 67.4/100 to 66.2/100, but only just.

MyFastRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MyFastRx is a cash-pay compounded-GLP-1 platform built around fast approval and discounted multi-month bundles. Nurx is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMyFastRx +15
75
60
Dose & formulationNurx +5
72
77
Clinical oversightNurx +13
66
79
Labs & monitoringEven
52
52
FulfillmentMyFastRx +18
83
65
Contract termsNurx +14
41
55
MyFastRx · left barNurx · right bar

The numbers

MetricMyFastRxNurx
WeighScore67.4/10066.2/100
GradeCC
Scorecard rank#170#200
Semaglutide$169/mo$179/mo (starting dose, compounded)
Tirzepatide$249/mo$179/mo (starting dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
MyFastRx

Graded #170 · C

Strengths

  • Aggressive 12-month bundle pricing — $99/mo semaglutide, $149/mo tirzepatide
  • LegitScript certified
  • All doses priced the same — no cost escalation as you titrate up
  • First-month promo discount lowers the trial barrier

Where it loses points

  • States served not disclosed — only 'multiple states' / 'licensed U.S. providers'
  • Corporate address and medical director not published
  • Pharmacy partner not named — only 'state-licensed pharmacies'
  • Cash-pay only — no insurance billing
  • Bundle savings require a large upfront commitment (12 months billed at once)
Nurx

Graded #200 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard